Mark Raffeld
Overview
Explore the profile of Mark Raffeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
256
Citations
13121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toloza F, Filie A, Raffeld M, Kebebew E, Klubo-Gwiezdzinska J, Gubbi S
JCEM Case Rep
. 2025 Feb;
3(3):luaf018.
PMID: 39944153
Thyroid nodules are one of the most commonly encountered conditions in clinical endocrinology. Most thyroid nodules are of epithelial origin. However, primary thyroid mesenchymal tumors (TMTs), arising from the mesenchymal...
2.
Arons E, Tai C, Suraj J, Liu Y, Day C, Raffeld M, et al.
Blood
. 2024 Dec;
PMID: 39719040
We found 18 patients with immunophenotype consistent with classic hairy cell leukemia (HCL) and BRAF mutations other than just V600E. Twelve had 1 non-V600E BRAF mutation and 6 had V600E...
3.
Chung H, Rajan S, Wu Z, Ferrone C, Raffeld M, Lee I, et al.
Acta Neuropathol
. 2024 Oct;
148(1):54.
PMID: 39422766
Astrocytomas that harbor recurrent genomic alterations in MYB or MYBL1 are a group of Pediatric-type diffuse low-grade gliomas that were newly recognized in the 2021 WHO Classification of Tumors of...
4.
Ozkaya N, Melloul Benizri S, Venkataraman G, Karai L, Fraitag S, Razanamahery J, et al.
Blood Adv
. 2024 Oct;
8(22):5796-5805.
PMID: 39361706
Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly understood entity characterized by accumulation of CD1a+/S100+ histiocytes (as Langerhans cell histiocytosis [LCH]) but with reduced-absent expression of Langerin/CD207. We...
5.
Vocke C, Ricketts C, Pack S, Raffeld M, Hewitt S, Lebensohn A, et al.
J Med Genet
. 2024 Sep;
61(11):1026-1030.
PMID: 39317422
von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the tumour suppressor gene. VHL patients are at increased risk of developing multiple benign...
6.
Ozogul E, Montaner A, Pol M, Frigola G, Balague O, Syrykh C, et al.
Blood Cancer J
. 2024 Sep;
14(1):166.
PMID: 39313500
Mantle cell lymphoma (MCL) is genetically characterized by the IG::CCND1 translocation mediated by an aberrant V(D)J rearrangement. CCND1 translocations and overexpression have been identified in occasional aggressive B-cell lymphomas with...
7.
Cheng J, Xi L, Jang Y, Kim J, Wang H, Pittaluga S, et al.
Haematologica
. 2024 Jun;
109(10):3363-3367.
PMID: 38867583
No abstract available.
8.
Raygada M, John L, Liu A, Schultz J, Thomas B, Bernstein D, et al.
J Cancer Res Clin Oncol
. 2024 May;
150(5):227.
PMID: 38700789
Introduction: Chordoma is a rare slow-growing tumor that occurs along the length of the spinal axis and arises from primitive notochordal remnants (Stepanek et al., Am J Med Genet 75:335-336,...
9.
Ganapathi K, Nicolae A, Egan C, Geng H, Xi L, Pack S, et al.
Br J Haematol
. 2024 Apr;
204(5):1862-1871.
PMID: 38613165
Peripheral T-cell lymphomas (PTCL) are morphologically and biologically heterogeneous and a subset expresses CD30, including anaplastic large cell lymphomas (ALCL) and a minority of PTCL, not otherwise specified (PTCL, NOS)....
10.
Pohl L, Leitheiser M, Obrecht D, Schweizer L, Wefers A, Eckhardt A, et al.
Acta Neuropathol
. 2024 Jan;
147(1):24.
PMID: 38265522
The diagnosis of ependymoma has moved from a purely histopathological review with limited prognostic value to an integrated diagnosis, relying heavily on molecular information. However, as the integrated approach is...